Sangamo Therapeutics Non-Current Deferred Revenue (Quarterly) Trends

Sangamo Therapeutics, Inc. (SGMO)

0.449 +0.01 (+1.35%) USD | NASDAQ | Jan 12, 16:00

0.4406 -0.01 (-1.87%) After-Hours: 06:22

View Non-Current Deferred Revenue (Quarterly) for SGMO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Arcturus Therapeutics Holdings, Inc.	Upgrade
AIM ImmunoTech, Inc.	--
Perspective Therapeutics, Inc.	Upgrade
Protalix Biotherapeutics, Inc.	--
Armata Pharmaceuticals, Inc.	--